(Q44992581)

8 December 2017

title

Hepatitis A vaccine in healthy adults: a comparison of immunogenicity and reactogenicity between two- and three-dose regimens (English)

1 reference

8 December 2017

1 reference

1 reference

4

1 reference

8 December 2017

Lu MY

1

1 reference

8 December 2017

Chang MH

series ordinal

2

1 reference

8 December 2017

Tsai KS

series ordinal

3

1 reference

8 December 2017

language of work or name

English

0 references

publication date

1 January 1999

1 reference

8 December 2017

1 reference

8 December 2017

volume

17

1 reference

8 December 2017

issue

1

1 reference

8 December 2017

page(s)

26-30

1 reference

Type A viral hepatitis. New developments in an old disease

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900149-2

7 January 2021

Incidence of Hepatitis A Virus Infection in Children in Taipei, Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900149-2

7 January 2021

Changing seroepidemiology of hepatitis A virus infection in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900149-2

7 January 2021

Safety and immunogenicity of hepatitis A vaccine in healthy adult volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900149-2

7 January 2021

An inactivated hepatitis A viral vaccine of cell culture origin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900149-2

7 January 2021

Immunogenicity of a killed hepatitis A vaccine in seronegative volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900149-2

7 January 2021

Immunogenicity of an inactivated hepatitis A vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900149-2

7 January 2021

Safety and immunogenicity of an inactivated hepatitis A candidate vaccine in healthy adult volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900149-2

7 January 2021

A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900149-2

7 January 2021

Approaches to a vaccine against hepatitis A: development and manufacture of an inactivated vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900149-2

7 January 2021

Will hepatitis A become a vaccine-preventable disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900149-2

7 January 2021

Immunogenicity of an inactivated hepatitis A vaccine administered according to two different schedules and the interference of other "travellers" vaccines with the immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900149-2

7 January 2021

Clinical experience with an inactivated hepatitis A vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900149-2

7 January 2021

Single-dose hepatitis A vaccination: comparison of different dose levels in adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900149-2

7 January 2021

A program to control an outbreak of hepatitis A in Alaska by using an inactivated hepatitis A vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900149-2

7 January 2021

Laboratory tests and reference reagents employed in studies of inactivated hepatitis A vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900149-2

7 January 2021

Safety and immunogenicity of an inactivated hepatitis A vaccine: effect of dose and vaccination schedule

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900149-2

7 January 2021

Immunogenicity of two versus three injections of inactivated hepatitis A vaccine in adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900149-2

7 January 2021

Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: rationale and summary of findings

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900149-2

7 January 2021

Evaluation of the timing of the booster injection after a primary vaccination against hepatitis A

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900149-2

7 January 2021

10.1016/S0264-410X(98)00149-2

Identifiers

DOI

1 reference

8 December 2017

1 reference